Letter to the Editor
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry
Eficacia y seguridad de baricitinib en pacientes con artritis reumatoide y respuesta inadecuada a FAME convencionales sintéticos o biológicos: datos de un registro local
Read
749
Timeswas read the article
260
Total PDF
417
Total HTML
72
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 March | 54 | 23 | 10 | 87 |
| 2023 February | 54 | 28 | 6 | 88 |
| 2023 January | 42 | 21 | 1 | 64 |
| 2022 December | 68 | 42 | 10 | 120 |
| 2022 November | 60 | 38 | 15 | 113 |
| 2022 October | 59 | 39 | 14 | 112 |
| 2022 September | 65 | 64 | 16 | 145 |
| 2022 August | 4 | 3 | 0 | 7 |
| 2022 July | 0 | 0 | 0 | 0 |
| 2022 June | 0 | 0 | 0 | 0 |
| 2022 May | 1 | 2 | 0 | 3 |
| 2022 April | 2 | 0 | 0 | 2 |
| 2022 March | 0 | 0 | 0 | 0 |
| 2022 February | 7 | 0 | 0 | 7 |
| 2022 January | 0 | 0 | 0 | 0 |
| 2021 December | 0 | 0 | 0 | 0 |
| 2021 November | 0 | 0 | 0 | 0 |
| 2021 October | 0 | 0 | 0 | 0 |
| 2021 September | 0 | 0 | 0 | 0 |
| 2021 August | 0 | 0 | 0 | 0 |
| 2021 July | 1 | 0 | 0 | 1 |
| 2021 June | 0 | 0 | 0 | 0 |
| 2021 May | 0 | 0 | 0 | 0 |
| 2021 April | 0 | 0 | 0 | 0 |
| 2021 March | 0 | 0 | 0 | 0 |
| 2021 February | 0 | 0 | 0 | 0 |
| 2021 January | 0 | 0 | 0 | 0 |
| 2020 December | 0 | 0 | 0 | 0 |
Show all
